Table 1.
Baseline characteristics of the study population
|
Women |
Men |
P-value | |
|---|---|---|---|
| N = 391 | N = 274 | ||
| Age, years, mean (SD) |
46 (6) |
46 (6) |
0.52 |
| Body mass index, kg/m2, mean (SD) |
26.3 (5.2) |
26.8 (3.6) |
0.21 |
| Waist, cm, mean (SD) |
83 (23) |
94 (10) |
<0.001 |
| Lipid lowering medication, n (%) |
5 (1) |
11 (4) |
0.023 |
| Antihypertensive medication, n (%) |
36 (9) |
33 (12) |
0.24 |
| Antihyperglycemic medication, n (%) |
1 (0) |
6 (2) |
0.022 |
| Total cholesterol, mmol/L, mean (SD) |
5.6 (0.97) |
5.7 (0.98) |
0.047 |
| HDL cholesterol, mmol/L, mean (SD) |
1.5 (0.33) |
1.3 (0.30) |
<0.001 |
| Triglycerides, mmol/L, mean (SD) |
1.2 (0.63) |
1.6 (0.92) |
<0.001 |
| Glucose, mmol/L, mean (SD) |
5.6 (0.59) |
5.9 (0.96) |
<0.001 |
| Insulin, mU/L, mean (SD) |
9.9 (7.3) |
10.3 (5.2) |
0.38 |
| Current smoking, n (%) |
80 (21) |
77 (27) |
0.024 |
| Reported use of alcohol, n (%) | 309 (79) | 239 (88) | 0.004 |